Clinical Characteristics And Response Outcomes in Older Multiple Myeloma Patients Who Received Idecabtagene Vicleucel : A Single Center Study​

Authors

Nilesh Kalariya, The University of Texas MD Anderson Cancer Center
Christopher Ferreri, The University of Texas MD Anderson Cancer Center
Christen Dillard, The University of Texas MD Anderson Cancer Center
Misha Hawkins, The University of Texas MD Anderson Cancer Center
Elisabet Manasanch, The University of Texas MD Anderson Cancer Center
Hans Lee, The University of Texas MD Anderson Cancer Center
Donna Weber, The University of Texas MD Anderson Cancer Center
Sheeba Thomas PhD, The University of Texas MD Anderson Cancer Center
Raphael Steiner, The University of Texas MD Anderson Cancer Center
Chitra Hosing, The University of Texas MD Anderson Cancer Center
Muzaffar H. Qazilbash, The University of Texas MD Anderson Cancer Center
Uday Popat, The University of Texas MD Anderson Cancer Center
Robert Orlowski, The University of Texas MD Anderson Cancer Center
Michelle Hiildebrandt, The University of Texas MD Anderson Cancer Center
Krina Patel, The University of Texas MD Anderson Cancer Center

Files

Description

Nilesh Kalariya pictured.

Publication Date

2022

Recommended Citation

Kalariya, Nilesh; Ferreri, Christopher; Dillard, Christen; Hawkins, Misha; Manasanch, Elisabet; Lee, Hans; Weber, Donna; Thomas, Sheeba PhD; Steiner, Raphael; Hosing, Chitra; Qazilbash, Muzaffar H.; Popat, Uday; Orlowski, Robert; Hiildebrandt, Michelle; and Patel, Krina, "Clinical Characteristics And Response Outcomes in Older Multiple Myeloma Patients Who Received Idecabtagene Vicleucel : A Single Center Study​" (2022). APRN Week 2022. 14.
https://openworks.mdanderson.org/aprn-week-22/14